Cervical cancer is increasingly being labelled as Canada’s “silent national health crisis,” with healthcare professionals urging the federal government to take decisive measures to combat this alarming trend. During a press conference held in Ottawa on Wednesday, the Society of Gynecologic Oncology of Canada highlighted the urgent need for enhanced prevention and screening strategies. Their call to action comes in response to the government’s action plan, announced in July 2025, which aims to eliminate cervical cancer as a public health issue by 2040. However, many experts warn that current measures are falling short.
Alarming Statistics Highlight a Growing Concern
Dr. Shannon Salvador, president of the Society of Gynecologic Oncology of Canada, underscored the severity of the situation, stating that approximately 1,650 Canadians were expected to be diagnosed with cervical cancer in 2025, resulting in around 430 deaths from a disease that is largely preventable. “Canada is currently serving a silent national health crisis,” Dr. Salvador noted. She pointed out that the reliance on traditional Pap testing and insufficient uptake of the human papillomavirus (HPV) vaccine are critical factors contributing to the rising incidence of this disease.
The completion rate for the HPV vaccine currently stands at a concerning 64 per cent, a figure Dr. Salvador described as “far below the target needed for elimination.” She emphasised that this statistic signifies not just a medical failure but a significant policy failure as well.
A Shift Towards Innovative Screening
In light of these challenges, the Society of Gynecologic Oncology of Canada is advocating for an immediate national transition to HPV DNA testing as a primary method for cervical cancer screening. They are also promoting the implementation of self-collection kits, designed to make screening more accessible for individuals who may face barriers in traditional healthcare settings. The Canadian Cancer Society has indicated that self-administered testing can be performed by collecting a small sample from the vagina, thus reducing the need for appointments in clinical settings.
Dr. Salvador explained that these at-home swabs could eliminate obstacles related to travel, past trauma, or lack of access to a family doctor. “There is a health gender gap that has persisted for years, particularly affecting rural, Indigenous, and underserved communities who are at risk of falling through the cracks of a fragmented system,” she asserted.
Addressing Systemic Barriers to Care
The urgency of reform is underscored by the experiences of Indigenous women, who are diagnosed with cervical cancer at higher rates and often present with more advanced stages of the disease. Dr. Sarah Kean, a provincial lead for cervical cancer in Manitoba, highlighted that these disparities are not rooted in biology but rather stem from systemic barriers such as geographic isolation, healthcare inequities, and the lingering effects of colonial practices.
Dr. Kean called for a comprehensive strategy that ensures robust, accessible HPV screening across Canada, supported by federal legislation. “Robust HPV screening must entail more than just updating guidelines; it requires universal access to primary HPV testing across all provinces and territories, along with established national standards,” she said.
The Financial Implications of Inaction
The financial burden of cervical cancer on the Canadian healthcare system is significant, with treatment costs projected at $132 million in 2024 alone. Dr. Salvador noted that the expense of screening eligible Canadians would total approximately $106 million over the next five years. This raises questions about the long-term sustainability of the current healthcare approach, particularly as other forms of cancer see declining incidence rates.
The Canadian Cancer Society’s November 2025 report indicates that cervical cancer remains the fourth most diagnosed cancer and the fourth leading cause of cancer-related deaths among women globally. Alarmingly, the rate of cervical cancer, which had been decreasing steadily from 1984 to 2005, has stagnated in recent years.
Why it Matters
The rising incidence of cervical cancer in Canada is a public health issue that demands immediate attention. As one of the most preventable cancers, the current state of affairs represents not only a failure of medical practice but also a significant shortfall in policy-making. With the right interventions, including improved access to HPV vaccinations and innovative screening methods, Canada has the potential to turn the tide on cervical cancer. The call to action from healthcare professionals is a crucial step towards ensuring that no one falls through the cracks of a system that is meant to protect and serve the health of all Canadians.
